Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
RGNX - OTHER CURRENT LIABILITIES
Other Current Liabilities RGNX - REGENXBIO Inc.
100 M
LAST VALUE
-0.32%
2 YEAR CAGR
43.57%
5 YEAR CAGR
39.10%
10 YEAR CAGR